홈 › 지방간질환 › 텍사스

텍사스의 지방간질환 임상 시험

지방간질환 관련 연구 20개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

GSK Investigational Site, Arlington
GSK Investigational Site, Austin
GSK Investigational Site, Dallas
외 4개

피험자 모집 중2상

18세 ~ 70세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT06613698

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Akero Clinical Study Site, Arlington
Akero Clinical Study Site, Austin
Akero Clinical Study Site, Austin
외 28개

피험자 모집 중3상

18세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06528314

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Texas Clinical Research Institute, LLC, Arlington
American Research Corporation, Austin
Methodist Dallas Medical Center, Dallas
외 4개

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07631637

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Pinnacle Clinical Research, Austin
Bellaire Clinical Research, Bellaire
South Texas Research Institute (STRI) - Brownsville, Brownsville
외 16개

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07288138

NAFLD Clinical Care Pathway

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

피험자 모집 중건강한 지원자 환영

18세 ~ 80세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06671886

Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Advanced Medical Trials, Georgetown

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07854782

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

GSK Investigational Site, Austin
GSK Investigational Site, Austin
GSK Investigational Site, Austin
외 10개

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06920043

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

GSK Investigational Site, Arlington
GSK Investigational Site, Austin
GSK Investigational Site, Austin
외 7개

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

GSK Investigational Site, Arlington
GSK Investigational Site, Austin
GSK Investigational Site, Austin
외 6개

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07701993

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

GSK Investigational Site, Houston
GSK Investigational Site, San Antonio

피험자 모집 중1상

18세 ~ 70세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07358546

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

First Surgical Hospital, Bellaire
Endeavor Clinical Trials, San Antonio

피험자 모집 중관찰 연구

18세 ~ 75세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07122700

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

89bio Clinical Study Site, Amarillo
89bio Clinical Study Site, Austin
89bio Clinical Study Site, Austin
외 18개

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

89bio Clinical Study Site, Amarillo
89bio Clinical Study Site, Austin
89bio Clinical Study Site, Austin
외 29개

피험자 모집 중3상

18세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT06318169

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

IMA Clinical Research Austin, Austin
American Research Corporation, Austin
Pinnacle Clinical Research, Austin
외 26개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07165028

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

American Research Corporation, Austin
Advanced Medical Trials, Georgetown
American Research Corporation at The Texas Liver Institute, San Antonio

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07527910

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site, Austin
GSK Investigational Site, Austin
GSK Investigational Site, Brownsville
외 12개

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07221188

Quantifying Hepatic Mitochondrial Fluxes in Humans

Texas Diabetes Institute - University Health System, San Antonio
University of Texas Health Science Center at San Antonio, San Antonio

피험자 모집 중4상

18세 ~ 80세 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05305287

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site, Arlington
GSK Investigational Site, Austin
GSK Investigational Site, Austin
외 16개

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07221227

Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population

Methodist Dallas Medical Center, Dallas

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT06225193

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Pioneer Research Solutions, Houston

피험자 모집 중1/2상건강한 지원자 환영

18세 ~ 75세 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT05648214

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.